Masaru Matsuda
Net worth: 3 M $ as of 2026-05-30
Net worth: 3 M $ as of 2026-05-30
Currently, Masaru Matsuda holds the position of Secretary, Chief Compliance Officer & SVP at Halozyme Therapeutics, Inc. Mr. Matsuda previously was Vice President-Law & Global Commercial Operations at Amgen, Inc. Mr. Matsuda received an undergraduate degree from the University of Southern California and a graduate degree from the University of California, Hastings.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-03 | 126,689 ( 0.1% ) | 3 M $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | General Counsel | 2021-12-31 |
| Companies | Position | End |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Compliance Officer | 2021-12-30 |
| AMGEN INC. | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Hastings
University of California, Hastings Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immunodermatology drug development company | Health Technology |
Select your edition
All financial news and data tailored to specific country editions